Fund HoldingsForesite Capital Management VI LLC

Total Portfolio Value
$330.84M
Total Bought
$44.47M
Total Sold
$17.12M
Net Transaction
+$27.34M
Filing Period:
Securities
SharesValue ($K)
Q3 2025
Q4 2025
Change
Q3 2025
Q4 2025
Weight (%)
Change
ALUMIS INC.4,247,6704,247,670016,94841,45712.53%+24,509
Natera, Inc.(NTRA)067,356+67,356015,4314.66%+15,431
AGIOS PHARMACEUTICALS, INC.(AGIO)0530,000+530,000014,4274.36%+14,427
RAPT Therapeutics, Inc.1,562,5001,562,500040,29752,92216.00%+12,625
Atai Beckley N.V.02,750,000+2,750,000011,2483.40%+11,248
Kymera Therapeutics, Inc.(KYMR)146,332146,33208,28211,3863.44%+3,104
CG Oncology, Inc.(CGON)2,221,4742,221,474089,48192,23627.88%+2,755
Centessa Pharmaceuticals plc1,314,0191,364,019+50,00031,86534,11410.31%+2,249
Denali Therapeutics Inc.(DNLI)1,000,0001,000,000014,52016,5104.99%+1,990
Verastem, Inc.2,615,1203,135,120+520,00023,09224,2037.32%+1,112
Hinge Health, Inc.(HNGE)135,000135,00006,6266,2711.90%-355
CASI Pharmaceuticals, Inc.979,9560-979,9561,6270-1,627
Avidity Biosciences, Inc.40,0000-40,0001,7430-1,743
Corvus Pharmaceuticals, Inc.(CRVS)1,731,2331,381,233-350,00012,75910,6353.21%-2,124
Akero Therapeutics, Inc.244,9000-244,90011,6280-11,628
Page 1 of 1